logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
D

David Planchard

gustave roussy

87H-index
985Paper Count
5.1WCitation Count
Published Papers 263
Publication Date
logo
Efficacy of Alectinib for ALK-positive NSCLC According to Tumor Burden and Body Mass Index: a Pooled Analysis of the Randomized Phase III Trials ALEX and J-ALEX
errEuropean Journal of Cancer
IF7.1
err2026-06-05
err0
errOAAI
errMarco Tagliamento; Marco Bruzzone; Eva Blondeaux; Filippo Dall’Olio; Mihaela Aldea; Carlo Genova; Arianna Marinello; Jordi Remon; Lizza E.L. Hendriks; Lucia Del Mastro; David Planchard; Fabrice Barlesi; Matteo Lambertini; Benjamin Besse
errShare
errSave
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors
errFuture Oncology
IF2.6
err2026-03-04
err0
PREAI
errAlison M. Schram; John J. Park; Antoine Italiano; Shigehisa Kitano; Ye Guo; Jin Li; Philippe L. Bedard; Cedric van Marcke; Ryo Ko; Lukas Lunger; Daniel M. Klotz; Jo Hussain; Daniela Maier; Damijan Erzen; David Planchard; Hans Prenen; Timothy D. Clay; Joon O. Park; Hyung-Don Kim; Alberto Hernando-Calvo; Yuta Maruki; Mariano Ponz-Sarvise; Ecaterina Dumbrava
errShare
errSave
First Line and Treatment Sequencing in EGFR-Mutated Metastatic NSCLC: What is Right for Which Patient?
errDrugs
IF14.4
err2026-01-31
err0
errOAAI
errPamela Abdayem; Claudia Parisi; David Planchard
errShare
errSave
Trastuzumab Deruxtecan in Patients with HER2-Overexpressing Non-Small Cell Lung Cancer: Results From Part 1 of the Open-label, Multicenter, Phase 1b DESTINY-Lung03 Trial
errJournal of Thoracic Oncology
IF20.8
err2025-12-23
err0
errOAAI
errDavid Planchard; Hye Ryun Kim; Thatthan Suksombooncharoen; Rubi Li; Diego Cortinovis; Ji-Youn Han; Jens Samol; Yotsawaj Runglodvatana; Kang-Yun Lee; Gee-Chen Chang; Chun-Hui Lee; Dariusz Kowalski; Stephanie P.L. Saw; Yiqing Huang; Gerrina Ruiter; Myung-Ju Ahn; Tsung-Ying Yang; Cheng-Ta Yang; Aumkhae Sookprasert; Erica C. Nakajima
errShare
errSave
The Rechallenge Benefit Score: A Clinical Decision Tool for Patients Progressing After Immunotherapy.
errEuropean Journal of Cancer
IF7.1
err2025-11-15
err0
PREAI
errCaroline Plazy; Mohamed Boussena; Linh Nguyen Phuong; Jean Baptiste Assié; Emmanuel Grolleau; Valerie Gounant; Chantal Decroisette; Eric Dansin; Catherine Daniel; Etienne Giroux Leprieur; David Planchard; Mariona Riudavets; Anthony Canellas; Youssef Oulkhouir; Maurice Pérol; Anne-Claire Toffart; Sebastien Benzekry; Elisa Gobbini
errShare
errSave
Real-world outcomes of second-line carboplatin plus pemetrexed after first-line osimertinib in EGFR-mutant advanced NSCLC: An international multicentre cohort study
errLung Cancer
IF4.4
err2025-10-16
err0
PREAI
errIgor Gomez-Randulfe; Federico Monaca; Ornella Cantale; Maria Lucia Reale; Loredana Mrak; Lodovica Zullo; Sofia Silva Diaz; Marta Zaragoza Bueno; Marya Alejandra Maridueña Moreno; Charlotte Davis; Samantha Cox; Daniel Lee; Riyaz Shah; Tom Geldart; Javier Baena; Jose Carlos Benitez; M.A. Rosario Garcia Campelo; Jordi Remon; David Planchard; Domenico Galetta; Marcello Tiseo; Diego Cortinovis; Giulio Metro; Emilio Bria; Francesco Passiglia; Silvia Novello; Raffaele Califano
errShare
errSave
Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-10-01
err5
PREAI
errJanne, Pasi A.; Planchard, David; Kobayashi, Kunihiko; Yang, James Chih-Hsin; Liu, Ying; Valdiviezo, Natalia; Kim, Tae Min; Jiang, Liyan; Kagamu, Hiroshi; Yanagitani, Noriko; Wang, Jialei; Biswas, Bivas; Poltoratskiy, Artem; Neron, Yeni; Rojas, Carlos; Koubkova, Leona; Escriu, Carles; Ezeife, Doreen A.; Mann, Helen; Armenteros-Monterroso, Elena; Rukazenkov, Yuri; Lee, Chee Khoon
errShare
errSave
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study
errThe Lancet Oncology
IF0
err2025-09-29
err0
PREAI
errAlessandro Di Federico; Kaiwen Wang; Monica F Chen; Adam A Barsouk; Arianna Pagliaro; Lanyi N Chen; Francesca R Ogliari; Paul Stockhammer; Rajat Thawani; Shahm Raslan; Eleonora Gariazzo; Francesca Fusco; Grace M Hambelton; Fabrizio Citarella; David Meyer; Mihaela Aldea; Andrea De Giglio; Joao V Alessi; Federica Pecci; Francesco Gelsomino; Marcelo Corassa; Natalie I Vokes; Xinan Wang; Dario de Biase; Fawzi Abu Rous; Phurin Areesawangkit; Omar Elghawy; Alessio Cortellini; Giulio Metro; Roberto Ferrara; Mark M Awad; Aliyah Pabani; Joseph C Murray; Federico Cappuzzo; Marina C Garassino; Ibiayi Dagogo-Jack; Gregory Riely; Michael Grant; Benjamin O Herzberg; Andrea Ardizzoni; David Planchard; Bruce E Johnson; Corey J Langer; Michael Offin; Marcelo V Negrao; Biagio Ricciuti
errShare
errSave
The impact of dual cannabis and tobacco smoking in young patients with lung cancer: results from the prospective “Environment and Lung Cancer” study
errCHEST
IF8.6
err2025-09-24
err0
PREAI
errP. Pradère; A. Marinello; D. Vasseur; C. Naltet; S. Moaca; J. Le Pavec; M.R. Ghigna; V. De Montpreville; J. Adam; L. Lacroix; F. Ben Sallem; C. Caramella; D. Planchard; O. Mercier; M. Aldea; J.C. Alvarez
errShare
errSave
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis
errBritish Journal of Cancer
IF6.8
err2025-09-11
err0
PREAI
errAbderaouf Hamza; Pierre Gestraud; Maryam Karimi; Alicia Tran-Dien; Laurène Syx; Sophie Vacher; Quentin Peretti; Ludovic Lacroix; Valery Attignon; Isabelle Soubeyran; Pascal Jézéquel; David Planchard; Samia Melaabi; Trenton Dailey-Chwalibóg; Marta Jimenez; Stefan Michiels; Nicolas Servant; Christophe Le Tourneau; Nicolas Girard; Fabrice André; Benjamin Besse; Maud Kamal; Fabrice Barlesi; Ivan Bièche
errShare
errSave
Final analysis results and patient-reported outcomes from DESTINY-Lung02—a dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic non–small cell lung cancer
errJournal of Thoracic Oncology
IF20.8
err2025-07-30
err0
PREAI
errPasi A. Jänne; Yasushi Goto; Toshio Kubo; Kiichiro Ninomiya; Sang-We Kim; David Planchard; Myung-Ju Ahn; Egbert Smit; Adrianus Johannes de Langen; Maurice Pérol; Elvire Pons-Tostivint; Silvia Novello; Hidetoshi Hayashi; Junichi Shimizu; Dong-Wan Kim; Kaline Pereira; Fu-Chih Cheng; Ayumi Taguchi; Yingkai Cheng; Kyle Dunton; Ahmed Ali; Koichi Goto
errShare
errSave
Evolving treatment for advanced non-small cell lung cancer harbouring common EGFR activating mutations
errCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
IF5.6
err2025-05-15
err0
PREAI
errGomez-Randulfe, Igor; Monaca, Federico; Planchard, David; Bria, Emilio; Califano, Raffaele
errShare
errSave
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers
errOncoImmunology
IF6.3
err2025-04-06
err0
errOAAI
errRoxanne Birebent; Damien Drubay; Carolina Alves Costa Silva; Federica Marmorino; Giacomo Vitali; Gianmarco Piccinno; Yoan Hurtado; Adele Bonato; Lorenzo Belluomini; Meriem Messaoudene; Bertrand Routy; Marine Fidelle; Gerard Zalcman; Julien Mazieres; Clarisse Audigier-Valette; Denis Moro-Sibilot; François Goldwasser; Arnaud Scherpereel; Hervé Pegliasco; François Ghiringhelli; Anna Reni; Fabrice Barlesi; Laurence Albiges; David Planchard; Stéphanie Martinez; Benjamin Besse; Nicola Segata; Chiara Cremolini; Laurence Zitvogel; Valerio Iebba; Lisa Derosa
errShare
errSave
BRAF in non-small cell lung cancer: From molecular mechanisms to clinical practice
errCANCER
IF5.1
err2025-04-02
err0
PREAI
errParisi, Claudia; Planchard, David
errShare
errSave
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN)
errClinical Lung Cancer
IF3.3
err2025-02-14
err0
PREAI
errMiguel García-Pardo; Marta García de Herreros; Juan Carlos Laguna; Teresa Gorría; Yolanda Lage; Ana Gómez; Mª Eugenia Olmedo; Pilar Garrido; Víctor Manuel Albarran-Artahona; Ainara Arcocha; Cristina Teixido; Noemí Reguart; Alejandro Navarro; Edouard Auclin; Mike S Nahorski; Karen Howarth; David Planchard; Benjamin Besse; Natasha B. Leighl; Laura Mezquita
errShare
errSave
Targeting DLL3: A New Weapon in Lung Neuroendocrine Tumors?
errJTO CLINICAL AND RESEARCH REPORTS
IF3.5
err2025-01-01
err0
errOAAI
errRiudavets, Mariona; Planchard, David
errShare
errSave
Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms
errVIRCHOWS ARCHIV
IF3.1
err2024-12-13
err0
PREAI
errKanaan, Christina; Bani, Mohamed-Amine; Ducreux, Michel; Planchard, David; Lamartina, Livia; Moog, Sophie; Pudlarz, Thomas; Baudin, Eric; Hadoux, Julien; Al-Ghuzlan, Abir; Scoazec, Jean-Yves
errShare
errSave
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives
errCANCER TREATMENT REVIEWS
IF10.5
err2024-12-01
err1
PREAI
errParisi, Claudia; Abdayem, Pamela; Tagliamento, Marco; Besse, Benjamin; Planchard, David; Remon, Jordi; Minuti, Gabriele; Cappuzzo, Federico; Barlesi, Fabrice
errShare
errSave
Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2024-11-28
err0
errOAAI
errDall'Olio, Filippo G.; Zrafi, Wael Salem; Blampey, Quentin; Danlos, Francois-Xavier; Roulleaux-Dugage, Matthieu; Roman, Gabriel; Naltet, Charles; Cournede, Paul-Henry; Gautheret, Daniel; Aldea, Mihaela; Planchard, David; Barlesi, Fabrice; Marabelle, Aurelien; Hulett, Tyler; Chaput-Gras, Nathalie; Besse, Benjamin
errShare
errSave
Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development
errMOLECULAR CANCER
IF33.9
err2024-10-04
err0
errOAAI
errVasseur, Damien; Bigot, Ludovic; Beshiri, Kristi; Florez-Arango, Juan; Facchinetti, Francesco; Hollebecque, Antoine; Tselikas, Lambros; Aldea, Mihaela; Blanc-Durand, Felix; Gazzah, Anas; Planchard, David; Lacroix, Ludovic; Pata-Merci, Noemie; Nobre, Catline; Da Silva, Alice; Nicotra, Claudio; Ngo-Camus, Maud; Braye, Floriane; Nikolaev, Sergey I.; Michiels, Stefan; Jules-Clement, Gerome; Olaussen, Ken Andre; Andre, Fabrice; Scoazec, Jean-Yves; Barlesi, Fabrice; Ponce, Santiago; Soria, Jean-Charles; Besse, Benjamin; Loriot, Yohann; Friboulet, Luc
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
G
Guido Kroemer
H-index: 283 · Papers: 2.3K
L
Laurence Zitvogel
H-index: 165 · Papers: 1.2K
P
Pasi A. Jänne
H-index: 163 · Papers: 2.3K
F
Fabrice André
H-index: 148 · Papers: 1.8K
J
James Chih‐Hsin Yang
H-index: 141 · Papers: 1.2K
View more